GlaxoSmithKline gets EC approval buy Pfizer's consumer health biz

GlaxoSmithKline gets EC approval to buy Pfizer's consumer health biz

9:28 AM, 16th July 2019
GlaxoSmithKline logo

BRUSSELS, BELGIUM: The European Commission has approved the acquisition of Pfizer's consumer health business by GlaxoSmithKline (GSK). The decision is conditional upon the global divestment of Pfizer's topical pain management business carried out under the ThermaCare brand.

GlaxoSmithKline (GSK) and Pfizer's consumer health business are both manufacturers and suppliers of a variety of consumer healthcare pharmaceuticals, which are typically available to patients without a prescription from a doctor and generally referred to as “over-the-counter” (OTC) pharmaceutical products.

Both companies are active in the European Economic Area (EEA) in a number of OTC product categories, namely topical pain management (creams, gels, spays and patches to treat pain locally), systemic pain management (products for oral intake targeting pain centrally), cold and flu treatments (e.g. multi-symptom treatments, antitussives), gastrointestinal treatments (e.g. antiacids, antiflatulents, antiulcerants), nutrition and digestive health (e.g. vitamins, supplements, laxatives), as well as sedatives and sleeping aids.

Based on the investigation, the Commission was concerned that the acquisition would reduce competition for topical pain management products, possibly resulting in price increases in a number of EEA countries, including Austria, Germany, Ireland, Italy and the Netherlands.

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

OMV plans to build €64 mn high-purity isobutene plant in Germany

VIENNA, AUSTRIA: OMV AG has decided to invest €64 million in the construction of an ISO C4 plant at Burghausen Refinery, Germany. OMV is an inter ...

Read more
DuPont opens world-class probiotics fermentation unit in New York

ROCHESTER, US: DuPont has opened a new state-of-the-art probiotics fermentation unit at its Rochester, New York, facility. Construction of the unit wa ...

Read more
McDermott wins contract for Sohar LNG bunkering project in Oman

HOUSTON, US: McDermott International Inc has been awarded a sizeable contract by Total Oman E&P Development BV in partnership with Oman Oil Compan ...

Read more
Gilead Sciences, Galapagos enter into R&D collaboration

FOSTER CITY, US. & MECHELEN, BELGIUM: Gilead Sciences Inc and Galapagos NV have entered into a 10-year global research and developm ...

Read more
Nippon Shokubai breaks ground on $200 mn acrylic acid plant

TOKYO, JAPAN: Nippon Shokubai Co Ltd’s subsidiary PT. Nippon Shokubai Indonesia held a ground-breaking ceremony for the new acrylic acid plant i ...

Read more
Teva Pharma purchases facilities in Pennsylvania for R&D campus

PARSIPPANY, US: Teva Pharmaceuticals USA Inc has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pennsylvania. Toget ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X